AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) announced that new data from two pivotal phase III clinical trials were presented at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE